Stablecoin Development Corp.
SDEV - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$39.14M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $39.14 Million |
|---|---|
| Enterprise Value | $32.17 Million |
| Annual dividend | $4.00 |
| Dividend yield | 259.74% |
| Earnings per Share | $-110.31 |
| Beta | 0.09 |
| Outstanding Shares | 31,048,000 |
Return
| Return on Equity | 379.93% |
|---|---|
| Return on Assets | 379.13% |
| Return on Invested Capital | -16.56% |
Valuation & Multiples
| P/E Ratio | 0.11 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | 0.26 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.53 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-0.55
Consensus analyst estimateRevenue Estimate
$3.30 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.60
Consensus analyst estimateRevenue Estimate
$3.80 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Novabay Pharmaceuticals Inc
4 employees
CEO: Justin Hall
Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the...